Guerbet
Philippe Bourrinet is a seasoned professional with extensive experience in the pharmaceutical industry, currently serving as Vice-President of Development, Medical & Regulatory Affairs at Guerbet since March 1994. In this role, Philippe has led Global Regulatory Affairs since March 2006 and has been responsible for non-clinical development since 1998. Prior to joining Guerbet, Philippe held various leadership positions at UPSA (now Bristol Myers Squibb), including Development Project Leader and Study Director in Pharmacokinetics. Philippe is an ERT - European Registered Toxicologist and holds advanced degrees in biodynamics, biopharmacy, and pharmacokinetics from prestigious institutions such as Université Paris Cité and Paris-Sud University.
This person is not in any offices
Guerbet
3 followers
Guerbet SA is a France-based pharmaceutical group specialized in the manufacture and marketing of medical imaging contrast agents destined for diagnostic purposes. It produces medical imaging contrast products for x-ray imaging, magnetic resonance imaging (MRI), ultrasound imaging and for nuclear medicine.